Skip to content
healthcare.dev
Get a free key

Allergy Relief

NDC 55910-930, Cetirizine HCl, tablet, from Dolgencorp, Inc. (DOLLAR GENERAL & REXALL).

Product NDC
55910-930
Status
Listed
Labeler
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA209274
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55910-930 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
55910-930-45559100930451 BOTTLE, PLASTIC in 1 BOX (55910-930-45) / 45 TABLET in 1 BOTTLE, PLASTIC
55910-930-90559100930901 BOTTLE, PLASTIC in 1 BOX (55910-930-90) / 90 TABLET in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 55910-930 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55910-930 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55910-930. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.